jama semaglutide naion may raise risk for nonarteritic anterior ischemic optic neuropathy in diabetes Semaglutide NAION Network Study Announcement

Garg SK, Lin F, Kandula N, Ding J, Carr J, Allison M, et al

Semaglutide also carries a warning about potential worsening of diabetic retinopathy complications, particularly in patients with pre-existing retinopathy

Aspirin may retain a role in select inflammatory or hereditary risk settings, while GLP-1 agents could become foundational for metabolically driven risk reduction

People qualify for Wegovy treatment if they have a BMI of 30 or higher (obesity) or 27 or higher with another weight-related problem like high blood pressure

I feel like a weight has been lifted off my shoulders." "Prior to being on this medication, I thought it was just a me problem, that there was just something that I wasn't getting right that other people were," Cooper told the outlet

Better Options Stop sulfonylureas once ESKD develops